170 related articles for article (PubMed ID: 36416093)
21. HPLC separation of naringin, neohesperidin and their C-2 epimers in commercial samples and herbal medicines.
Uchiyama N; Kim IH; Kikura-Hanajiri R; Kawahara N; Konishi T; Goda Y
J Pharm Biomed Anal; 2008 Apr; 46(5):864-9. PubMed ID: 17532169
[TBL] [Abstract][Full Text] [Related]
22. Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China.
Lu Y; Zhang C; Bucheli P; Wei D
Plant Foods Hum Nutr; 2006 Jun; 61(2):57-65. PubMed ID: 16816988
[TBL] [Abstract][Full Text] [Related]
23. Flavanones: Citrus phytochemical with health-promoting properties.
Barreca D; Gattuso G; Bellocco E; Calderaro A; Trombetta D; Smeriglio A; Laganà G; Daglia M; Meneghini S; Nabavi SM
Biofactors; 2017 Jul; 43(4):495-506. PubMed ID: 28497905
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
Kanaze FI; Bounartzi MI; Georgarakis M; Niopas I
Eur J Clin Nutr; 2007 Apr; 61(4):472-7. PubMed ID: 17047689
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of neohesperidin and poncirin isolated from the fruits of Poncirus trifoliata on potential gastric disease.
Lee JH; Lee SH; Kim YS; Jeong CS
Phytother Res; 2009 Dec; 23(12):1748-53. PubMed ID: 19367677
[TBL] [Abstract][Full Text] [Related]
26. Hesperidin potentiates ghrelin signaling.
Suzuki H; Asakawa A; Kawamura N; Yagi T; Inui A
Recent Pat Food Nutr Agric; 2014; 6(1):60-3. PubMed ID: 25176345
[TBL] [Abstract][Full Text] [Related]
27. Chemistry and pharmacology of the Citrus bioflavonoid hesperidin.
Garg A; Garg S; Zaneveld LJ; Singla AK
Phytother Res; 2001 Dec; 15(8):655-69. PubMed ID: 11746857
[TBL] [Abstract][Full Text] [Related]
28. Hesperetin's health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations.
Salehi B; Cruz-Martins N; Butnariu M; Sarac I; Bagiu IC; Ezzat SM; Wang J; Koay A; Sheridan H; Adetunji CO; Semwal P; Schoebitz M; Martorell M; Sharifi-Rad J
Crit Rev Food Sci Nutr; 2022; 62(16):4449-4464. PubMed ID: 33491467
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of Citrus flavonoids on starch digestion and antihyperglycemic effects in HepG2 cells.
Shen W; Xu Y; Lu YH
J Agric Food Chem; 2012 Sep; 60(38):9609-19. PubMed ID: 22958058
[TBL] [Abstract][Full Text] [Related]
30. Multi-target inhibition ability of neohesperidin dictates its neuroprotective activity: Implication in Alzheimer's disease therapeutics.
Chakraborty S; Rakshit J; Bandyopadhyay J; Basu S
Int J Biol Macromol; 2021 Apr; 176():315-324. PubMed ID: 33581209
[TBL] [Abstract][Full Text] [Related]
31. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
Benavente-García O; Castillo J
J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
[TBL] [Abstract][Full Text] [Related]
32. Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Mas-Capdevila A; Teichenne J; Domenech-Coca C; Caimari A; Del Bas JM; Escoté X; Crescenti A
Nutrients; 2020 May; 12(5):. PubMed ID: 32443766
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evidence for the pharmacological actions of naringin: a review.
Bharti S; Rani N; Krishnamurthy B; Arya DS
Planta Med; 2014 Apr; 80(6):437-51. PubMed ID: 24710903
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological effects of harmine and its derivatives: a review.
Zhang L; Li D; Yu S
Arch Pharm Res; 2020 Dec; 43(12):1259-1275. PubMed ID: 33206346
[TBL] [Abstract][Full Text] [Related]
35. Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways.
Banjerdpongchai R; Wudtiwai B; Khaw-On P; Rachakhom W; Duangnil N; Kongtawelert P
Tumour Biol; 2016 Jan; 37(1):227-37. PubMed ID: 26194866
[TBL] [Abstract][Full Text] [Related]
36. Metabolic engineering of plant cells for biotransformation of hesperedin into neohesperidin, a substrate for production of the low-calorie sweetener and flavor enhancer NHDC.
Frydman A; Weisshaus O; Huhman DV; Sumner LW; Bar-Peled M; Lewinsohn E; Fluhr R; Gressel J; Eyal Y
J Agric Food Chem; 2005 Dec; 53(25):9708-12. PubMed ID: 16332119
[TBL] [Abstract][Full Text] [Related]
37. Hydrolysis of flavanone glycosides and degradation of the corresponding aglycones from dried immature Citrus fruit by human fecal flora in vitro.
Wang X; Sakurai T; Chen X; Sun H; Wang Z; Sun Q; Sun W; Cao H
Planta Med; 2008 Nov; 74(14):1751-5. PubMed ID: 18975261
[TBL] [Abstract][Full Text] [Related]
38. Current advances on the therapeutic potential of pinocembrin: An updated review.
Elbatreek MH; Mahdi I; Ouchari W; Mahmoud MF; Sobeh M
Biomed Pharmacother; 2023 Jan; 157():114032. PubMed ID: 36481404
[TBL] [Abstract][Full Text] [Related]
39. Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin--a mini-review.
Roohbakhsh A; Parhiz H; Soltani F; Rezaee R; Iranshahi M
Life Sci; 2014 Sep; 113(1-2):1-6. PubMed ID: 25109791
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the interaction for three Citrus flavonoids and α-amylase by surface plasmon resonance.
Liu X; Luo F; Li P; She Y; Gao W
Food Res Int; 2017 Jul; 97():1-6. PubMed ID: 28578029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
